This effort will use low-cost medical technologies to help reduce the estimated 5.4 million newborn deaths annually worldwide. This grant also is Save the Children's largest private gift in its history. MMV's goal is to register one new anti-malarial drug every five years, starting in 2010.
Hookworm infections are one of the main causes of anemia and malnutrition worldwide.
The Institute will work closely with Corixa, a biotechnology company. Reply to this article, click here . For more news about giving, please visit our archive .